Cassava Sciences

2.34
开盘价
2.19
市值
114.97M+
最高价
2.49
最低价
2.19
收盘价
2.38
成交量
2.09M+
市盈率
-1.63
股息率
0.00%

Cassava Sciences简介

木薯科学公司致力于新药和诊断的开发。它专注于开发用于治疗阿尔茨海默病的候选产品,包括PTI-125和PTI-125Dx。该公司由雷米·巴比尔和巴里·M·谢尔曼于1998年5月创立,总部设在德克萨斯州奥斯汀。

如何购买 Cassava Sciences (SAVA)

登录
1分钟开户

1分钟开户

仅需1分钟即可完成账户申请和验证。整个过程完全自助,支持 RockFlow App 和网页端操作。

充值资金

充值资金

账户验证完成后,您可以使用首选的支付方式向账户充值。

购买 SAVA

购买 SAVA

通过 RockFlow App 或网页端搜索 SAVA,输入您想要投资的金额,然后点击确认即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.